APO Research
Talk to an analyst

APO RESEARCH · REPORT

Emerging Cancer Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Emerging Cancer Vaccines Industry Growth and Trends Forecast to 2032

22 December 202599 pages

Choose your research edition.

Industry ResearchEmerging Cancer Vaccines Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Emerging Cancer Vaccines Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Emerging Cancer Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Emerging Cancer Vaccines Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Emerging Cancer Vaccines Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Emerging Cancer Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Emerging Cancer Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Emerging Cancer Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Emerging Cancer Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Emerging Cancer Vaccines include Merck, GlaxoSmithKline, Northwest Biotherapeutics, Moderna, Avax Technologies and Antigenics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Emerging Cancer Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Emerging Cancer Vaccines market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Emerging Cancer Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Emerging Cancer Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Emerging Cancer Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Emerging Cancer Vaccines Market by Company

Merck

GlaxoSmithKline

Northwest Biotherapeutics

Moderna

Avax Technologies

Antigenics

Emerging Cancer Vaccines Segment by Type

Non Genetic Vaccines

Genetic Vaccines

Emerging Cancer Vaccines Segment by Application

Cancer Research Centers

Cancer Hospital

Clinics

Others

Emerging Cancer Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Emerging Cancer Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Emerging Cancer Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Emerging Cancer Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Emerging Cancer Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Emerging Cancer Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Non Genetic Vaccines Table 2. Major Company of Genetic Vaccines Table 3. Global Emerging Cancer Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Emerging Cancer Vaccines Sales by Type (2021-2026) & (k units) Table 5. Global Emerging Cancer Vaccines Sales Market Share in Volume by Type (2021-2026) Table 6. Global Emerging Cancer Vaccines Sales by Type (2021-2026) & (US$ Million) Table 7. Global Emerging Cancer Vaccines Sales Market Share in Value by Type (2021-2026) Table 8. Global Emerging Cancer Vaccines Price by Type (2021-2026) & (US$/unit) Table 9. Global Emerging Cancer Vaccines Sales by Type (2027-2032) & (k units) Table 10. Global Emerging Cancer Vaccines Sales Market Share in Volume by Type (2027-2032) Table 11. Global Emerging Cancer Vaccines Sales by Type (2027-2032) & (US$ Million) Table 12. Global Emerging Cancer Vaccines Sales Market Share in Value by Type (2027-2032) Table 13. Global Emerging Cancer Vaccines Price by Type (2027-2032) & (US$/unit) Table 14. North America Emerging Cancer Vaccines Sales by Type (2021-2026) & (k units) Table 15. North America Emerging Cancer Vaccines Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Emerging Cancer Vaccines Sales by Type (2021-2026) & (k units) Table 17. Europe Emerging Cancer Vaccines Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Emerging Cancer Vaccines Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Emerging Cancer Vaccines Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Emerging Cancer Vaccines Sales by Type (2021-2026) & (k units) Table 21. Latin America Emerging Cancer Vaccines Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Emerging Cancer Vaccines Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Emerging Cancer Vaccines Sales by Type (2021-2026) & (US$ Million) Table 24. Emerging Cancer Vaccines Industry Trends Table 25. Emerging Cancer Vaccines Industry Drivers Table 26. Emerging Cancer Vaccines Industry Opportunities and Challenges Table 27. Emerging Cancer Vaccines Industry Restraints Table 28. Global Emerging Cancer Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Emerging Cancer Vaccines Revenue Market Share by Company (2021-2026) Table 30. Global Emerging Cancer Vaccines Sales by Company (2021-2026) & (k units) Table 31. Global Emerging Cancer Vaccines Sales Share by Company (2021-2026) Table 32. Global Emerging Cancer Vaccines Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Emerging Cancer Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Emerging Cancer Vaccines Major Company Production Sites and Headquarters Table 35. Global Emerging Cancer Vaccines Company, Product Type & Application Table 36. Global Emerging Cancer Vaccines Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Emerging Cancer Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Emerging Cancer Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Emerging Cancer Vaccines Sales by Region (2021-2026) & (k units) Table 41. Global Emerging Cancer Vaccines Sales Market Share in Volume by Region (2021-2026) Table 42. Global Emerging Cancer Vaccines Sales by Region (2021-2026) & (US$ Million) Table 43. Global Emerging Cancer Vaccines Sales Market Share in Value by Region (2021-2026) Table 44. Global Emerging Cancer Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Emerging Cancer Vaccines Sales by Region (2027-2032) & (k units) Table 46. Global Emerging Cancer Vaccines Sales Market Share in Volume by Region (2027-2032) Table 47. Global Emerging Cancer Vaccines Sales by Region (2027-2032) & (US$ Million) Table 48. Global Emerging Cancer Vaccines Sales Market Share in Value by Region (2027-2032) Table 49. Global Emerging Cancer Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Emerging Cancer Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Emerging Cancer Vaccines Sales by Application (2021-2026) & (k units) Table 52. Global Emerging Cancer Vaccines Sales Market Share in Volume by Application (2021-2026) Table 53. Global Emerging Cancer Vaccines Sales by Application (2021-2026) & (US$ Million) Table 54. Global Emerging Cancer Vaccines Sales Market Share in Value by Application (2021-2026) Table 55. Global Emerging Cancer Vaccines Price by Application (2021-2026) & (US$/unit) Table 56. Global Emerging Cancer Vaccines Sales by Application (2027-2032) & (k units) Table 57. Global Emerging Cancer Vaccines Sales Market Share in Volume by Application (2027-2032) Table 58. Global Emerging Cancer Vaccines Sales by Application (2027-2032) & (US$ Million) Table 59. Global Emerging Cancer Vaccines Sales Market Share in Value by Application (2027-2032) Table 60. Global Emerging Cancer Vaccines Price by Application (2027-2032) & (US$/unit) Table 61. North America Emerging Cancer Vaccines Sales by Application (2021-2026) & (k units) Table 62. North America Emerging Cancer Vaccines Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Emerging Cancer Vaccines Sales by Application (2021-2026) & (k units) Table 64. Europe Emerging Cancer Vaccines Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Emerging Cancer Vaccines Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Emerging Cancer Vaccines Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Emerging Cancer Vaccines Sales by Application (2021-2026) & (k units) Table 68. Latin America Emerging Cancer Vaccines Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Emerging Cancer Vaccines Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Emerging Cancer Vaccines Sales by Application (2021-2026) & (US$ Million) Table 71. Merck Company Information Table 72. Merck Business Overview Table 73. Merck Emerging Cancer Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Merck Emerging Cancer Vaccines Product Portfolio Table 75. Merck Recent Development Table 76. GlaxoSmithKline Company Information Table 77. GlaxoSmithKline Business Overview Table 78. GlaxoSmithKline Emerging Cancer Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. GlaxoSmithKline Emerging Cancer Vaccines Product Portfolio Table 80. GlaxoSmithKline Recent Development Table 81. Northwest Biotherapeutics Company Information Table 82. Northwest Biotherapeutics Business Overview Table 83. Northwest Biotherapeutics Emerging Cancer Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Northwest Biotherapeutics Emerging Cancer Vaccines Product Portfolio Table 85. Northwest Biotherapeutics Recent Development Table 86. Moderna Company Information Table 87. Moderna Business Overview Table 88. Moderna Emerging Cancer Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Moderna Emerging Cancer Vaccines Product Portfolio Table 90. Moderna Recent Development Table 91. Avax Technologies Company Information Table 92. Avax Technologies Business Overview Table 93. Avax Technologies Emerging Cancer Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Avax Technologies Emerging Cancer Vaccines Product Portfolio Table 95. Avax Technologies Recent Development Table 96. Antigenics Company Information Table 97. Antigenics Business Overview Table 98. Antigenics Emerging Cancer Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Antigenics Emerging Cancer Vaccines Product Portfolio Table 100. Antigenics Recent Development Table 101. North America Emerging Cancer Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 102. North America Emerging Cancer Vaccines Sales by Country (2021-2026) & (k units) Table 103. North America Emerging Cancer Vaccines Sales Market Share by Country (2021-2026) Table 104. North America Emerging Cancer Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 105. North America Emerging Cancer Vaccines Sales Market Share Forecast by Country (2027-2032) Table 106. North America Emerging Cancer Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Emerging Cancer Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Emerging Cancer Vaccines Market Share by Country (2021-2026) Table 109. North America Emerging Cancer Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Emerging Cancer Vaccines Market Share Forecast by Country (2027-2032) Table 111. Europe Emerging Cancer Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 112. Europe Emerging Cancer Vaccines Sales by Country (2021-2026) & (k units) Table 113. Europe Emerging Cancer Vaccines Sales Market Share by Country (2021-2026) Table 114. Europe Emerging Cancer Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 115. Europe Emerging Cancer Vaccines Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Emerging Cancer Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Emerging Cancer Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Emerging Cancer Vaccines Market Share by Country (2021-2026) Table 119. Europe Emerging Cancer Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Emerging Cancer Vaccines Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Emerging Cancer Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Emerging Cancer Vaccines Sales by Country (2021-2026) & (k units) Table 123. Asia-Pacific Emerging Cancer Vaccines Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Emerging Cancer Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 125. Asia-Pacific Emerging Cancer Vaccines Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Emerging Cancer Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Emerging Cancer Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Emerging Cancer Vaccines Market Share by Country (2021-2026) Table 129. Asia-Pacific Emerging Cancer Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Emerging Cancer Vaccines Market Share Forecast by Country (2027-2032) Table 131. Latin America Emerging Cancer Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. Latin America Emerging Cancer Vaccines Sales by Country (2021-2026) & (k units) Table 133. Latin America Emerging Cancer Vaccines Sales Market Share by Country (2021-2026) Table 134. Latin America Emerging Cancer Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 135. Latin America Emerging Cancer Vaccines Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Emerging Cancer Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Emerging Cancer Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Emerging Cancer Vaccines Market Share by Country (2021-2026) Table 139. Latin America Emerging Cancer Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Emerging Cancer Vaccines Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Emerging Cancer Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Emerging Cancer Vaccines Sales by Country (2021-2026) & (k units) Table 143. Middle East and Africa Emerging Cancer Vaccines Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Emerging Cancer Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 145. Middle East and Africa Emerging Cancer Vaccines Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Emerging Cancer Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Emerging Cancer Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Emerging Cancer Vaccines Market Share by Country (2021-2026) Table 149. Middle East and Africa Emerging Cancer Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Emerging Cancer Vaccines Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Emerging Cancer Vaccines Distributors List Table 154. Emerging Cancer Vaccines Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Emerging Cancer Vaccines Image Figure 2. Global Emerging Cancer Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Emerging Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Emerging Cancer Vaccines Sales (2021-2032) & (k units) Figure 5. Non Genetic Vaccines Image Figure 6. Global Non Genetic Vaccines Sales YoY Growth (2021-2032) & (k units) Figure 7. Genetic Vaccines Image Figure 8. Global Genetic Vaccines Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Emerging Cancer Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Emerging Cancer Vaccines Market Share by Type 2025 VS 2032 Figure 11. North America Emerging Cancer Vaccines Sales Market Share in Volume by Type in 2025 Figure 12. North America Emerging Cancer Vaccines Sales Market Share in Value by Type in 2025 Figure 13. Europe Emerging Cancer Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. Europe Emerging Cancer Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Emerging Cancer Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Emerging Cancer Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Latin America Emerging Cancer Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Emerging Cancer Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Emerging Cancer Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Emerging Cancer Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Emerging Cancer Vaccines Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Cancer Research Centers Image Figure 24. Global Cancer Research Centers Sales YoY Growth (2021-2032) & (k units) Figure 25. Cancer Hospital Image Figure 26. Global Cancer Hospital Sales YoY Growth (2021-2032) & (k units) Figure 27. Clinics Image Figure 28. Global Clinics Sales YoY Growth (2021-2032) & (k units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Emerging Cancer Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Emerging Cancer Vaccines Market Share by Application 2025 VS 2032 Figure 33. North America Emerging Cancer Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. North America Emerging Cancer Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Europe Emerging Cancer Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Europe Emerging Cancer Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Emerging Cancer Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Emerging Cancer Vaccines Sales Market Share in Value by Application in 2025 Figure 39. Latin America Emerging Cancer Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Emerging Cancer Vaccines Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Emerging Cancer Vaccines Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Emerging Cancer Vaccines Sales Market Share in Value by Application in 2025 Figure 43. North America Emerging Cancer Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Emerging Cancer Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Emerging Cancer Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Emerging Cancer Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Emerging Cancer Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Emerging Cancer Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Emerging Cancer Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Emerging Cancer Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Emerging Cancer Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Emerging Cancer Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Emerging Cancer Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Emerging Cancer Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Emerging Cancer Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Emerging Cancer Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Emerging Cancer Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Emerging Cancer Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Emerging Cancer Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Emerging Cancer Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Emerging Cancer Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Emerging Cancer Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Emerging Cancer Vaccines Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Emerging Cancer Vaccines Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Non Genetic Vaccines
  • Genetic Vaccines
Applications
  • Cancer Research Centers
  • Cancer Hospital
  • Clinics
  • Others
Companies covered
  • Merck
  • GlaxoSmithKline
  • Northwest Biotherapeutics
  • Moderna
  • Avax Technologies
  • Antigenics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Emerging Cancer Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Emerging Cancer Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Emerging Cancer Vaccines Market by Type
  6. 1.3.1 Non Genetic Vaccines
  7. 1.3.2 Genetic Vaccines
  8. 1.4 Global Emerging Cancer Vaccines Market Size by Type
  9. 1.4.1 Global Emerging Cancer Vaccines Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Emerging Cancer Vaccines Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Emerging Cancer Vaccines Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Emerging Cancer Vaccines Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Emerging Cancer Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Emerging Cancer Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Emerging Cancer Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Emerging Cancer Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Emerging Cancer Vaccines Industry Trends
  2. 2.2 Emerging Cancer Vaccines Industry Drivers
  3. 2.3 Emerging Cancer Vaccines Industry Opportunities and Challenges
  4. 2.4 Emerging Cancer Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Emerging Cancer Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Emerging Cancer Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Emerging Cancer Vaccines Price (2021-2026)
  4. 3.4 Global Emerging Cancer Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Emerging Cancer Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Emerging Cancer Vaccines Company, Product Type & Application
  7. 3.7 Global Emerging Cancer Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Emerging Cancer Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Emerging Cancer Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Emerging Cancer Vaccines Tier 1, Tier 2, and Tier 3
4 Emerging Cancer Vaccines Regional Status and Outlook
  1. 4.1 Global Emerging Cancer Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Emerging Cancer Vaccines Historic Market Size by Region
  3. 4.2.1 Global Emerging Cancer Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Emerging Cancer Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Emerging Cancer Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Emerging Cancer Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Emerging Cancer Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Emerging Cancer Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Emerging Cancer Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Emerging Cancer Vaccines by Application
  1. 5.1 Emerging Cancer Vaccines Market by Application
  2. 5.1.1 Cancer Research Centers
  3. 5.1.2 Cancer Hospital
  4. 5.1.3 Clinics
  5. 5.1.4 Others
  6. 5.2 Global Emerging Cancer Vaccines Market Size by Application
  7. 5.2.1 Global Emerging Cancer Vaccines Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Emerging Cancer Vaccines Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Emerging Cancer Vaccines Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Emerging Cancer Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Emerging Cancer Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Emerging Cancer Vaccines Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Emerging Cancer Vaccines Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Emerging Cancer Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck Emerging Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck Emerging Cancer Vaccines Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 GlaxoSmithKline
  8. 6.2.1 GlaxoSmithKline Company Information
  9. 6.2.2 GlaxoSmithKline Business Overview
  10. 6.2.3 GlaxoSmithKline Emerging Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GlaxoSmithKline Emerging Cancer Vaccines Product Portfolio
  12. 6.2.5 GlaxoSmithKline Recent Developments
  13. 6.3 Northwest Biotherapeutics
  14. 6.3.1 Northwest Biotherapeutics Company Information
  15. 6.3.2 Northwest Biotherapeutics Business Overview
  16. 6.3.3 Northwest Biotherapeutics Emerging Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Northwest Biotherapeutics Emerging Cancer Vaccines Product Portfolio
  18. 6.3.5 Northwest Biotherapeutics Recent Developments
  19. 6.4 Moderna
  20. 6.4.1 Moderna Company Information
  21. 6.4.2 Moderna Business Overview
  22. 6.4.3 Moderna Emerging Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Moderna Emerging Cancer Vaccines Product Portfolio
  24. 6.4.5 Moderna Recent Developments
  25. 6.5 Avax Technologies
  26. 6.5.1 Avax Technologies Company Information
  27. 6.5.2 Avax Technologies Business Overview
  28. 6.5.3 Avax Technologies Emerging Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Avax Technologies Emerging Cancer Vaccines Product Portfolio
  30. 6.5.5 Avax Technologies Recent Developments
  31. 6.6 Antigenics
  32. 6.6.1 Antigenics Company Information
  33. 6.6.2 Antigenics Business Overview
  34. 6.6.3 Antigenics Emerging Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Antigenics Emerging Cancer Vaccines Product Portfolio
  36. 6.6.5 Antigenics Recent Developments
7 North America by Country
  1. 7.1 North America Emerging Cancer Vaccines Sales by Country
  2. 7.1.1 North America Emerging Cancer Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Emerging Cancer Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Emerging Cancer Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Emerging Cancer Vaccines Market Size by Country
  6. 7.2.1 North America Emerging Cancer Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Emerging Cancer Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Emerging Cancer Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Emerging Cancer Vaccines Sales by Country
  2. 8.1.1 Europe Emerging Cancer Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Emerging Cancer Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Emerging Cancer Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Emerging Cancer Vaccines Market Size by Country
  6. 8.2.1 Europe Emerging Cancer Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Emerging Cancer Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Emerging Cancer Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Emerging Cancer Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Emerging Cancer Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Emerging Cancer Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Emerging Cancer Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Emerging Cancer Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Emerging Cancer Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Emerging Cancer Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Emerging Cancer Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Emerging Cancer Vaccines Sales by Country
  2. 10.1.1 South America Emerging Cancer Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Emerging Cancer Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Emerging Cancer Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Emerging Cancer Vaccines Market Size by Country
  6. 10.2.1 South America Emerging Cancer Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Emerging Cancer Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Emerging Cancer Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Emerging Cancer Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Emerging Cancer Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Emerging Cancer Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Emerging Cancer Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Emerging Cancer Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Emerging Cancer Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Emerging Cancer Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Emerging Cancer Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Emerging Cancer Vaccines Value Chain Analysis
  2. 12.1.1 Emerging Cancer Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Emerging Cancer Vaccines Production Mode & Process
  7. 12.2 Emerging Cancer Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Emerging Cancer Vaccines Distributors
  10. 12.2.3 Emerging Cancer Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst